Bioheart Inc. (BHRT) 0.0070 $BHRT Bioheart CEO Tomas

New Post Public Reply Private Reply Replies (0) Message Board

Jul 11, 2015 at 11:32 AM

Bioheart Inc. (BHRT) 0.0070 $BHRT

Bioheart CEO Tomas Voted Top Entrepreneur
ACCESSWIRE - Mon Jun 08, 8:01AM CDT
SUNRISE, FL / ACCESSWIRE / June 8, 2015 / Bioheart, Inc., a Florida Corporation (OTC:BHRT) announces today that Mike Tomas, President and CEO of Bioheart, Inc. was voted by the Miami Today newspaper editorial board, in its June 4, 2015 special edition, as one of Miami's top entrepreneurs: Miami Today, June 4, 2015: The Best of Miami 2015; Best of entrepreneurs find opportunity, play in the unknown.

Bioheart Enters Agreement to Acquire Pavillion Scientific
ACCESSWIRE - Wed Jun 03, 8:02AM CDT
SUNRISE, FL / ACCESSWIRE / June 3, 2015 / Bioheart, Inc., a Florida Corporation (OTCQB: BHRT) announces today that it has entered into an letter of intent to acquire Pavillion Scientific, Inc. (Florida) a wholly owned subsidiary of Pavillion Foods, Inc. (Florida). Pavillion Scientific is the provider of stem cell collection kits to both Bioheart, Inc and Vetbiologics. Management believes that the acquisition of Pavillion Scientific by Bioheart will enable Bioheart and Vetbiologics to significantly reduce their cost of goods sold and correspondingly increase their gross margin on sales. Under the terms of the letter of intent, Pavillion Foods, Inc. will receive cash, future royalties on a defined number of unit sales and Bioheart Common Stock warrants to purchase Bioheart Common Stock at a predetermined price. Upon completion of a Definitive Agreement, of which there are no assurances will be consummated, Pavillion Scientific will become an operating division of Bioheart, Inc.

Bioheart Chairman Affirms Corporate Strategy Through Stock Purchase - REVISED
ACCESSWIRE - Sat May 23, 10:44AM CDT
Untitled Document

Bioheart Chairman Affirms Corporate Strategy Through Stock Purchase
ACCESSWIRE - Fri May 22, 12:52PM CDT
SUNRISE, FL / ACCESSWIRE / May 22, 2015 / Bioheart, Inc., a Florida Corporation (OTCQB: BHRT) announces today that Dr. William P. Murphy, Jr., Bioheart's Chairman purchased 2,873,564 shares of Bioheart Common Stock in an open market transaction valued at $28,735.64 or $0.01 per share. The purchase of Bioheart Common Stock by Dr. Murphy was made at a premium to Bioheart's currently trading price per share. Subsequent to the purchase, Dr. Murphy owns 16,016,412 shares of Bioheart Common Stock.

Bioheart Highlights Positive First Quarter Results
ACCESSWIRE - Wed May 06, 7:02AM CDT
SUNRISE, FL / ACCESSWIRE / May 6, 2015 / Bioheart, Inc., a Florida Corporation (OTCQB:BHRT) highlights today the positive results from its first quarter 2015 operations:

Kristin Comella, CSO Blogs with Paul Knoepfler on Bioheart and US Stem Cell Clinic and Training
ACCESSWIRE - Wed Apr 22, 8:02AM CDT
SUNRISE, FL / ACCESSWIRE / April 22, 2015 / Bioheart, Inc., a Florida Corporation (BHRT.OB) announces today that Kristin Comella's blog interview with Paul Knoepfler, the Knoepfler Lab Stem Cell Blog is available on line through the following link:

Bioheart Posts Contact Information for its Upcoming Conference Call
ACCESSWIRE - Mon Apr 20, 11:17AM CDT
SUNRISE, FL / ACCESSWIRE / APRIL 20, 2015 / Bioheart, Inc., a Florida Corporation (OTCQB: BHRT) announces today the following contact information for its 1st Quarter Preview Conference Call to be held on Thursday, April 23rd at 4:30 EDT. Participants can join the call through the Company's GoToMeeting portal or by phone using the following links:

US Stem Cell Clinic Increases Staff to Support Patient Demand and Marketing
ACCESSWIRE - Thu Apr 16, 11:01AM CDT
SUNRISE, FL / ACCESSWIRE / April 16, 2015 / Bioheart, Inc., a Florida Corporation (OTCQB: BHRT) announces today that its US Stem Cell Clinic division has increased its staff to support increasing patient demand and the creation and launch of new marketing initiatives.

Bioheart to Preview Positive 1st Quarter Results in Upcoming Conference Call
ACCESSWIRE - Wed Apr 15, 11:20AM CDT
SUNRISE, FL / ACCESSWIRE / April 15, 2015 / Bioheart, Inc., a Florida Corporation (OTCQB: BHRT) announces today that it will hold a 1st Quarter Review Conference Call on Thursday, April 23rd, 2015 at 4:30 PM EDT. The call will highlight research and development, business and corporate accomplishments for the first quarter of 2015 and goals for the second quarter. Webinar and dial-in numbers for the conference call will be posted on Monday, April 20, 2015.

Sell Great Basin Scientific Inc., Penny Stock Newsletter Pumps Don't End Well
Big Banks - at Seeking Alpha - Mon Apr 06, 2:31PM CDT

GNMK: 8.69 (+0.15), GBSN: 2.81 (-0.06), RCAP: 5.25 (+0.14), QDEL: 22.74 (+0.40), CPHD: 58.15 (+0.75), RTGN: 5.06 (+1.01)

Bioheart and Ascyrus Medical Execute Investment Agreement
ACCESSWIRE - Thu Mar 19, 8:31AM CDT
SUNRISE, FL / ACCESSWIRE / March 19, 2015 / Bioheart, Inc., a Florida Corporation (OTCQB:BHRT) and Ascyrus Medical, LLC, a Florida Limited Liability Corporation are pleased to announce that they have entered into an investment agreement. The investment agreement provides for Bioheart to obtain a consolidating ownership stake in Ascyrus Medical upon the achievement of certain business milestones. Bioheart has through June 30, 2015 to meet its milestone obligations.

Bioheart Touts 2014 Accomplishments; Seeks More in 2015
ACCESSWIRE - Tue Mar 17, 1:27PM CDT
SUNRISE, FL / ACCESSWIRE / March 17, 2015 / Bioheart, Inc., a Florida Corporation (OTCQB:BHRT), an emerging enterprise in the regenerative medicine / cellular therapy industry is pleased to announce, following the release of its Form 10-K Annual Report, key 2014 accomplishments including but not limited to:

Bioheart Strengthens Management Team with Appointment of Martin E. Schmieg as President of Vetbiologics, Inc.
ACCESSWIRE - Wed Feb 11, 10:18AM CST
SUNRISE, FL / ACCESSWIRE / February 11, 2015 / Bioheart, Inc., a Florida Corporation (BHRT.OB), an emerging enterprise in the regenerative medicine / cellular therapy industry announced today the appointment of Martin E. Schmieg as President of Vetbiologics, Inc., the Company's wholly owned animal health subsidiary.

Bioheart Updates and Diversifies Its Clinical Development Pipeline
ACCESSWIRE - Thu Jan 29, 9:00AM CST
SUNRISE, FL / ACCESSWIRE / January 29, 2015 / Bioheart, Inc., a Florida Corporation (OTCQB:BHRT), an emerging enterprise in the regenerative medicine / cellular therapy industry announced today an update and diversification plan for its clinical development pipeline. The company's update includes a realignment of its cardiovascular product candidates and diversification into the treatment of autoimmune diseases with a first generation, investigational research program to treat Rheumatoid Arthritis (RA).

Bioheart Confirms Date and Access for Shareholder Conference Call
ACCESSWIRE - Wed Jan 28, 9:00AM CST
Strategic Direction for 2015 and Forward to be Highlighted

Bioheart to repurchase shares
Seeking Alpha - at Seeking Alpha - Fri Jan 16, 11:38AM CST

Bioheart Announces Date for Shareholder Conference Call
ACCESSWIRE - Wed Jan 14, 9:00AM CST
Strategic Direction for 2015 and Forward to be Highlighted

Bioheart Board of Directors Authorizes a Repurchase of the Company's Outstanding Common Stock
ACCESSWIRE - Tue Jan 13, 9:01AM CST
SUNRISE, FL / ACCESSWIRE / January 13, 2015 / Bioheart, Inc. (OTCQB:BHRT), a biotechnology company focused on the discovery, development and commercialization of autologous cell therapies a Florida corporation, today announced that its Board of Directors has approved a share repurchase program authorizing the Company to repurchase outstanding Common Stock when beneficially prudent for the Company and its shareholders.

Bioheart Announces Completion of First Stem Cell Training in Australia
ACCESSWIRE - Mon Dec 22, 9:09AM CST
SUNRISE, FL / ACCESSWIRE / December 22, 2014 / Bioheart, Inc. (BHRT.OB), a biotechnology company focused on the discovery, development and, subject to United States regulatory approval, commercialization of autologous cell therapies for the treatment of degenerative diseases, announces completion of the first stem cell training course to bring regenerative therapies to Australia. (www.usstemcelltraining.com)

Bioheart Announces Joint Venture In Nigeria
ACCESSWIRE - Thu Dec 18, 7:01AM CST
SUNRISE, FL / ACCESSWIRE / December 18, 2014 / Bioheart, Inc. (OTCQB:BHRT), a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of degenerative diseases, announced today that it has entered into a joint venture with Dr. Prosper Igboeli of Nigeria.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cumberland Pharmaceuticals Eyes NDA for Ifetroban in DMD

Rolling the Dice with Ifetroban There's a buzz in the air around Cumberland Pharmaceuticals as they gear up to tackle one of medicine's stubborn giants, Duchenne muscular dystrophy (DMD). They plan to file a New Drug Application (NDA) with the FDA for ifetroban, aiming to treat the cardiomyopathy plaguing many DMD sufferers. Folks who’ve watched Cumberland (NASDAQ:CPIX)...

AI Deepfakes Met Their Match: IC-Corp's New Patent

The Deepfake Fraud Reality Slap You know, in a world where you can't trust your own eyes on a video call, trust gets a bit sketchy, right? Imagine this scenario—an unsuspecting finance employee, surrounded by familiar faces and voices, only to wind up sending $25.6 million to fraudsters who weren't even real. A chilling real-world example from January 2024, courtesy of...

Investor Scrutiny Intensifies Over M&A Deals at SGRY, RRC, EQT

When Insiders Seem to Benefit More Ah, mergers and acquisitions—it's the oldest tango in the business world. But today, we've got some footwork that might trip up the small fry. Halper Sadeh LLC, the investor rights bulldogs, are sniffing around Surgery Partners, Range Resources, and EQT. Their quest? To uncover whether the big dogs are playing unfairly with...

Mission Bancorp Hits Record Earnings, Extends Buyback

Record-Breaking Quarter Amid Challenging Times When Mission Bancorp's earnings hit the tape today, the numbers were enough to catch anyone's eye—$9.2 million in net income for Q3 2026, a 6% increase from last year. That's not small potatoes, especially considering the economic fog we're navigating through. AJ Antongiovanni, holding the reins as CEO, credits the bank's...

Columbia Distributing Expands to Alaska: A Growth Move

Alaska's Entry: Columbia's New Frontier When Columbia Distributing dives into a new territory, you know they're serious about growth. This latest move sees them planting their flag in Alaska, finally completing a strategic vision that's been brewing for a while. Four-State Strategy Comes to Fruition The transaction with Republic National Distributing Company (RNDC) is no...

ADSQUIRE Dominates 2026 with Jaw-Dropping ROI and Award

ADSQUIRE's Phenomenal ROI Grabs Industry Spotlight Just when you think the PPC world has seen it all, ADSQUIRE steps in and flips the script. With a jaw-dropping 8,000% return on investment (ROI) from a mere $4,000 ad spend in just one month, they've taken the PPC Agency of the Year title at the 2026 Search Engine Land Awards. For a Philadelphia-based agency focused on...

Duke Energy's Battle Against Energy Vampires Heats Up

Unplugging Hidden Electricity Drains Ever wonder why your electric bill has been sneakily creeping up? You might think it's just the AC running full blast or lights left on, but surprise, surprise—there’s a whole army of “energy vampires” quietly sucking the juice out of your home. Duke Energy Florida is drawing attention to this sneaky leak, especially around...

Brennan Takes a Swing: Barrasso Endorsement in Hand

Brennan Shakes Up Wyoming Politics You don’t need a crystal ball to see the chess game unfolding in Wyoming's political landscape. Shannon Brennan's bid for the House seat in Teton County's District 23 got a heavy artillery boost today. She’s landed the endorsement of Senator John Barrasso, none other than the Senate Majority Whip and a formidable player in the Senate...

ROKAE Hits 10,000 Delivery Mark for Robotic Arms

ROKAE's Big 10K: A Milestone Worth Noting Alright, if you've been around the block as long as I have, you know the robotics game isn't just about making cool gadgets—it's about hitting those serious deployment numbers. ROKAE Robotics just rolled its 10,000th humanoid force-controlled arm off the line in Shandong, and this ain't just another notch on their belt. This...

Revamp Preschool Questions for Richer Conversations

Preschoolers, those tiny agents of chaos, come home with stories that you'd need a magnifying glass to find. Ask 'em "How was school?" and you're met with blank stares or a one-liner. Tami Nix of Archway Academy has been at this game for over 40 years, and she's got a trick or six up her sleeve. Ditch the Generic: Get Specific Yep, those generic questions are about as...